Items tagged with Drug-resistant TB
Advocates call on Otsuka to reduce the price of delamanid (post with simple image)
Advocates ask Otsuka to lower the price of delamanid in line with Médecins sans Frontières target regimen cost of $500.
Médecins Sans Frontières calls on Johnson & Johnson to cut key TB drug price in half (post with simple image)
Warns high prices of TB drugs restrict people's access to best drug-resistant TB treatment.
Activists urge National TB Programs and treatment providers to discontinue use of harmful injectable agents in TB treatment (post with simple image)
In a symbolic display, activists invited conference participants to discard the injectable agents and commit to rapidly scaling up access to safer, more effective medicine.
Activists interrupt TB conference opening ceremony to call on J&J to cut price of TB drug in half, to one dollar per day (post with simple image)
Activists demand that Johnson & Johnson cut the price of bedaquiline in half, to no higher than $1 per day—$32 per person per month—double the price that researchers estimate bedaquiline could be sold for a profit.
Advocates call on Indian government to improve its response to drug-resistant TB (post with simple image)
Advocates call for minimizing the use of injectable agents and scaling up universal drug susceptibility testing.
WHO updates its treatment guidelines for MDR/RR-TB (post with simple image)
The updated WHO treatment guidelines recommend that drug-resistant TB be treated with oral drugs only, including newer, more potent drugs with fewer side effects.
TB activists for first time challenge TB drug patent in India (post with simple image)
TB activists for first time challenge TB drug patent in India, in bid to prevent Johnson & Johnson from extending monopoly.
TB CAB statement on safety of using bedaquiline and delamanid together (post with simple image)
Global TB CAB welcomes confirmation of safety of using bedaquiline and delamanid together, urges uptake.
TAG statement on FDA priority review of pretomanid (post with simple image)
Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid.
New WHO recommendations to accelerate progress on TB (post with simple image)
WHO issues new guidance to improve treatment of multidrug-resistant TB.
Page 85 of 88 · Total posts: 0←First 84 85 86 Last→